Human immunodeficiency virus type 1 encoded viral protein Vpr is essential for infection of macrophages by HIV-1. Furthermore, these macrophages are resistant to cell death and are viral reservoir. However, the impact of Vpr on the macrophage proteome is yet to be comprehended. The goal of the present study was to use a stable-isotope labeling by amino acids in cell culture (SILAC) coupled with mass spectrometry-based proteomics approach to characterize the Vpr response in macrophages. Cultured human monocytic cells, U937, were differentiated into macrophages and transduced with adenovirus construct harboring the Vpr gene. More than 600 proteins were quantified in SILAC coupled with LC-MS/MS approach, among which 136 were significantly altered upon Vpr overexpression in macrophages. Quantified proteins were selected and clustered by biological functions, pathway and network analysis using Ingenuity computational pathway analysis. The proteomic data illustrating increase in abundance of enzymes in the glycolytic pathway (pentose phosphate and pyruvate metabolism) was further validated by western blot analysis. In addition, the proteomic data demonstrate down regulation of some key mitochondrial enzymes such as glutamate dehydrogenase 2 (GLUD2), adenylate kinase 2 (AK2) and transketolase (TKT). Based on these observations we postulate that HIV-1 hijacks the macrophage glucose metabolism pathway via the Vpr-hypoxia inducible factor 1 alpha (HIF-1 alpha) axis to induce expression of hexokinase (HK), glucose-6-phosphate dehyrogenase (G6PD) and pyruvate kinase muscle type 2 (PKM2) that facilitates viral replication and biogenesis, and long-term survival of macrophages. Furthermore, dysregulation of mitochondrial glutamate metabolism in macrophages can contribute to neurodegeneration via neuroexcitotoxic mechanisms in the context of NeuroAIDS.
References
[1]
Amini S, Khalili K, Sawaya BE (2004) Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol 23: 249–260.
[2]
Le Rouzic E, Benichou S (2005) The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2: 11.
[3]
Planelles V, Benichou S (2009) Vpr and its interactions with cellular proteins. Curr Top Microbiol Immunol 339: 177–200.
[4]
Kogan M, Rappaport J (2011) HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8: 25.
[5]
Zhao RY, Li G, Bukrinsky MI (2011) Vpr-host interactions during HIV-1 viral life cycle. J Neuroimmune Pharmacol 62: 216–229.
[6]
Sharifi HJ, Furuya AM, de Noronha CM (2012) The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest. Curr Opin HIV AIDS 7: 187–194.
[7]
Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995 206: 935–944.
[8]
Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, et al. (2001) HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med 194: 1407–1419.
[9]
Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, et al. (1998) Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med 187: 1103–1111.
[10]
Jacquot G, Le Rouzic E, David A, Mazzolini J, Bouchet J, et al. (2007) Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 4: 84.
[11]
Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, et al. (2004) High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate withHIV-1-associated dementia. DNA Cell Biol 23: 261–269.
[12]
Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ (1995) Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem 270: 25564–25569.
[13]
Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S (1998) Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J Biol Chem 273: 20052–20057.
[14]
Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, et al. (2002) HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J Biol Chem 277: 37820–37831.
[15]
Arokium H, Kamata M, Chen I (2009) Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol 83: 11283–11297.
[16]
Saxena M, Busca A, Pandey S, Kryworuchko M, Kumar A (2011) CpG protects human monocytic cells against HIV-Vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner. J Immunol 187: 5865–5878.
[17]
Patel CA, Mukhtar M, Pomerantz RJ (2000) Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 74: 9717–9726.
[18]
Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, et al. (2011) Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. J Biol Chem 286: 34976–34985.
[19]
Godet AN, Guergnon J, Croset A, Cayla X, Falanga PB, et al. (2010) PP2A1 binding, cell transducing and apoptotic properties of Vpr(77–92): a new functional domain of HIV-1 Vpr proteins. PLoS One 5: e13760.
[20]
Busca A, Saxena M, Kumar A (2012) Critical role for antiapoptotic Bcl-xL and Mcl-1in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. J Biol Chem 287: 15118–15133.
[21]
Smolka MB, Zhou H, Purkayastha S, Aebersold R (2001) Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis. Anal Biochem 297: 25–31.
[22]
Zieske LR (2006) A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57: 1501–1508.
[23]
Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376–386.
[24]
Duan X, Kelsen SG, Clarkson AB Jr R, Merali S (2010) SILAC analysis of oxidative stress-mediated proteins in human pneumocytes: new role for treacle. Proteomics 10: 2165–2174.
[25]
Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, et al. (1992) An unusual macrophage-trophic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66: 7517–7521.
[26]
Dyrlund TF, Poulsen ET, Scavenius C, Sanggaard KW, Enghild JJ (2012) MS Data Miner: A web-based software tool to analyze, compare and share mass spectrometry protein identifications. Proteomics 12: 2792–2796.
[27]
Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, et al. (2009) Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem 284: 11364–11373.
[28]
Navare AT, Sova P, Purdy DE, Weiss JM, Wolf-Yadlin A, et al. (2012) Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 429: 37–46.
[29]
Meléndez LM, Colon K, Rivera L, Rodriguez-Franco E, Toro-Nieves D (2011) Proteomic analysis of HIV-infected macrophages. J Neuroimmune Pharmacol 6: 89–106.
[30]
Wiederin J, Rozek W, Duan F, Ciborowski P (2009) Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci. 7: 8.
[31]
Pendyala G, Trauger SA, Kalisiak E, Ellis RJ, Siuzdak G, et al. (2009) Cerebrospinalfluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J Proteome Res 8: 2253–2260.
[32]
Toro-Nieves DM, Rodriguez Y, Plaud M, Ciborowski P, Duan F, et al. (2009) Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment. J Neurovirol 15: 36–50.
[33]
Wang T, Gong N, Liu J, Kadiu I, Kraft-Terry SD, et al. (2008) Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One 3: e2507.
[34]
Ringrose JH, Jeeninga RE, Berkhout B, Speijer D (2008) Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 82: 4320–4330.
[35]
Ricardo-Dukelow M, Kadiu I, Rozek W, Schlautman J, Persidsky Y, et al. (2007) HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 185: 37–46.
[36]
Chen X, Zheng Y, Li H, Mamadou D, Zhang C, et al. (2011) The Vpr gene polymorphism of human immunodeficiency virus type 1 in China and its clinical significance. Curr HIV Res 9: 295–299.
[37]
Wu JQ, Dyer WB, Chrisp J, Belov L, Wang B, et al. (2008) Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy. Retrovirology 5: 24.
[38]
Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2008) Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology 380: 124–135.
[39]
Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2011) Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology 8: 18.
[40]
Wu JQ, Sassé TR, Wolkenstein G, Conceicao V, Saksena MM, et al. (2013) Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. Virology 435: 308–319.
[41]
Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, et al. (2012) A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 13: 677.
[42]
Marín-Hernández A, Gallardo-Pérez JC, Rodríguez-Enríquez S, Encalada R, Moreno-Sánchez R, et al. (2011) Modeling cancer glycolysis. Biochim Biophys Acta 1807: 755–767.
[43]
Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V (2004) In self-defense: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 377: 347–355.
[44]
Stanton RC (2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64: 362–369.
[45]
Cosentino C, Grieco D, Costanzo V (2011) ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30: 546–555.
[46]
Luo W, Hu H, Chang R, Zhong J, Knabel M, et al. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732–744.
[47]
Reynolds JL, Mahajan SD, Bindukumar B, Sykes D, Schwartz SA, et al. (2006) Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res 1123: 226–236.
[48]
Rivera-Rivera L, Perez-Laspiur J, Colón K, Meléndez LM (2012) Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs. J Neurovirol 18: 20–29.
[49]
Gao X, Wang H, Yang JJ, Liu X, Liu ZR (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598–609.
[50]
Yang W, Xia Y, Hawke D, Li X, Liang J, et al. (2012) PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150: 685–696.
[51]
Huber K, Doyon G, Plaks J, Fyne E, Mellors JW, et al. (2011) Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells. J Biol Chem 286: 22211–22218.
[52]
Tjernlund A, Walther-Jallow L, Behbahani H, Screpanti V, Nowak P, et al. (2007) Leukemia inhibitor factor (LIF) inhibits HIV-1 replication via restriction of stat 3 activation. AIDS Res Hum Retroviruses 23: 398–406.
[53]
Raimundo N, Baysal BE, Shadel GS (2011) Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med 17: 641–649.
[54]
Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, et al. (2010) Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol 8: e1000328.
[55]
Hollenbaugh JA, Munger J, Kim B (2011) Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology 415: 153–159.
[56]
Sargent PJ, Farnaud S, Evans RW (2005) Structure/function overview of proteins involved in iron storage and transport. Curr Med Chem 12: 2683–2693.
[57]
Tacchini L, Gammella E, De Ponti C, Recalcati S, Cairo G (2008) Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J Biol Chem 283: 20674–20686.
[58]
Takeuchi S (2006) Molecular cloning, sequence, function and structural basis of human heart 150 kDa oxygen-regulated protein, an ER chaperone. Protein J 25: 517–528.
[59]
Ni M, Lee AS (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641–3651.
[60]
Cechowska-Pasko M, Bankowski E, Chene P (2006) The effect of hypoxia on the expression of 150 kDa oxygen-regulated protein (ORP 150) in HeLa cells. Cell Physiol Biochem 17: 89–96.
[61]
J？ger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, et al. (2011) Global landscape of HIV-human protein complexes. Nature 481: 365–370.
[62]
Merk M, Baugh J, Zierow S, Leng L, Pal U, et al. (2009) The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. J Immunol 182: 6896–6906.
[63]
Yedavalli VS, Jeang KT (2011) Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expression. Retrovirology 20 8: 61.
[64]
Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445–600.
[65]
Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z (2000) Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases Cancer Research. 60: 4053–4057.
[66]
Plaitakis A, Latsoudis H, Spanaki C (2011) The human GLUD2 glutamate dehydrogenase and its regulation in health and disease. Neurochem Int 59: 495–509.
[67]
Noma T (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J Med Invest 52: 127–136.
[68]
Lee HJ, Pyo JO, Oh Y, Kim HJ, Hong SH, et al. (2007) AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 29: 1303–1310.
[69]
Zhao J, Zhong CJ (2009) A review on research progress of transketolase. Neurosci Bull 25: 94–99.
